MAPK12

MAPK12

Introduction

Mapk12 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

MAPK12 (Mitogen-Activated Protein Kinase 12), also known as p38-gamma or ERK6, is a member of the p38 family of MAP kinases. It is activated by cellular stress, inflammatory cytokines, and growth factors. MAPK12 is expressed in various tissues, with particularly high expression in skeletal muscle and brain, where it regulates diverse cellular processes including cell differentiation, stress responses, and synaptic plasticity. [@mapk]

Function

MAPK12 participates in multiple cellular signaling pathways: [@mapka]

• Stress-Activated Kinase Pathway: MAPK12 is activated by cellular stresses including UV radiation, oxidative stress, and inflammatory cytokines (TNF-α, IL-1).
• Cell Differentiation: MAPK12 plays roles in muscle cell differentiation and neuronal development.
• Synaptic Plasticity: In [neurons](/entities/neurons), MAPK12 is involved in regulating synaptic strength and plasticity, processes critical for learning and memory.
• Inflammatory Responses: MAPK12 contributes to the production of inflammatory mediators in glial cells.

Role in Neurodegeneration

MAPK12 has complex roles in neurodegenerative diseases: [@kinase]

...

MAPK12

Introduction

Mapk12 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

MAPK12 (Mitogen-Activated Protein Kinase 12), also known as p38-gamma or ERK6, is a member of the p38 family of MAP kinases. It is activated by cellular stress, inflammatory cytokines, and growth factors. MAPK12 is expressed in various tissues, with particularly high expression in skeletal muscle and brain, where it regulates diverse cellular processes including cell differentiation, stress responses, and synaptic plasticity. [@mapk]

Function

MAPK12 participates in multiple cellular signaling pathways: [@mapka]

• Stress-Activated Kinase Pathway: MAPK12 is activated by cellular stresses including UV radiation, oxidative stress, and inflammatory cytokines (TNF-α, IL-1).
• Cell Differentiation: MAPK12 plays roles in muscle cell differentiation and neuronal development.
• Synaptic Plasticity: In [neurons](/entities/neurons), MAPK12 is involved in regulating synaptic strength and plasticity, processes critical for learning and memory.
• Inflammatory Responses: MAPK12 contributes to the production of inflammatory mediators in glial cells.

Role in Neurodegeneration

MAPK12 has complex roles in neurodegenerative diseases: [@kinase]

• Alzheimer's Disease: MAPK12 is activated in AD brains and may contribute to [tau](/proteins/tau) phosphorylation and [amyloid-beta](/proteins/amyloid-beta)-induced toxicity. However, its role is context-dependent and may involve both protective and detrimental effects.
• Parkinson's Disease: MAPK12 activation in dopaminergic neurons may be involved in the cellular response to oxidative stress. Inhibition of p38 MAPK pathways has been explored as a therapeutic strategy in PD models.
• Amyotrophic Lateral Sclerosis (ALS): MAPK12 is activated in motor neurons and glial cells in ALS, contributing to inflammatory responses and disease progression.
• Multiple Sclerosis: In animal models of MS, MAPK12/p38-gamma deficiency results in more severe disease, suggesting a protective role.
• Neuroinflammation: As a regulator of cytokine production, MAPK12 influences neuroinflammatory processes common to many neurodegenerative conditions.

Gene Information

<div class="infobox infobox-gene"> [@neuroinflammation]
<div class="infobox-header">Gene Information</div>
<div class="infobox-content"> Symbol: MAPK12 Full Name: Mitogen-Activated Protein Kinase 12 Chromosome: 22q13.1 Molecular Weight: ~42 kDa Protein Class: Serine/Threonine Protein Kinase Aliases: p38-gamma, ERK6, SAPK3
</div>
</div>

Protein Structure

MAPK12 contains the characteristic features of p38 MAP kinases:

• Kinase Domain: Catalytic domain responsible for phosphoryltransferase activity
• TEY Activation Loop: Threonine-Glutamate-Tyrosine motif phosphorylated by upstream MAPKKs (MKK3, MKK6)
• CD Domain: Common docking domain for interaction with regulators and substrates

MAPK12 is activated by MKK3 and MKK6, which phosphorylate its Thr180 and Tyr182 residues.

Expression Pattern

MAPK12 exhibits tissue-specific expression:

• Highest in skeletal muscle
• Moderate expression in heart, brain, and lung
• In the brain: expressed in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum, and spinal cord
• Cellular localization: primarily cytosolic, translocates to nucleus upon activation

Therapeutic Implications

MAPK12 and related p38 kinases are therapeutic targets:

• p38 Inhibitors: Several small molecule inhibitors have been developed, though toxicity has limited clinical applications.
• Anti-inflammatory Strategies: Modulating MAPK12 may reduce neuroinflammation in AD, PD, and ALS.
• Neuroprotection: Selective targeting of MAPK12 over other p38 isoforms could provide benefits with fewer side effects.

Interactions

• MKK3/MKK6: Upstream activators that phosphorylate MAPK12
• MAPKAPK2/3: Substrates downstream of MAPK12
• STAT3: MAPK12 can phosphorylate and regulate STAT3 signaling
• MSK1/2: Nuclear MAPK12 substrates involved in transcription regulation

Pathway & Interaction Diagram

Interactive diagram showing MAPK12's key relationships in the SciDEX knowledge graph (5 connections shown).

See Also

• [MAPK Signaling](/mechanisms/mapk-signaling-neurodegeneration))
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Tau Pathology](/mechanisms/tau-pathology)

Background

The study of Mapk12 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

Unknown, MAPK12/p38-gamma in brain function and disease (n.d.)

Unknown, p38 MAPK in Alzheimer's disease pathogenesis (n.d.)

Unknown, MAPK12 and synaptic plasticity (n.d.)

Unknown, p38 kinase inhibitors for neurodegenerative diseases (n.d.)

Unknown, Neuroinflammation and MAPK signaling in PD (n.d.)